AIDS Weekly articles from September 1992

AIDS Weekly archives from September 1992

Enrollment in D4T Phase II/III trial reaches 500. (anti-HIV drug) (Bristol-Myers Squibb)
September 28, 1992... Bristol-Myers Squibb Enrollment in a major Phase II/III clinical trial of d4T has reached 500 participants, according to the drug's manufacturer. The one-year trial, which began in May 1992, has a target enrollment of 700....

Research on anti-HIV Antigen Formulation reported. (IDEC Pharmaceuticals)
September 28, 1992... IDEC Pharmaceuticals IDEC Pharmaceuticals Corp., La Jolla, California, announced results of early stage preclinical research on an Antigen Formulation that appears to enhance induction of disease-fighting cellular immunity. The...

Vaccine alliance announced. (Cambridge Biotech/Genentech)
September 28, 1992... Cambridge Biotech/Genentech Cambridge Biotech Corp. (CBC), Worcester, Massachusetts, announced it has agreed to license its proprietary QS-21 Stimulon adjuvant to Genentech Inc. for use in an AIDS vaccine. The companies were...

TLC G-65 Phase III trial in Europe started. (Mycobacterium avium-intracellulare therapy) (The Liposome Co.)
September 28, 1992... The Liposome Co. TLC G-65, a potential Mycobacterium avium-intracellulare (MAI) therapy, has entered a Phase III clinical trial in Europe, the Liposome Co. Inc., Princeton, New Jersey, announced. The MAI study was initiated at...

Company files for U.S. patent on new AIDS drug invention. (cytochalasin D and dextran complex) (Polydex)
September 28, 1992... Polydex Thomas C. Usher, chairman of Polydex Pharmaceuticals Ltd. (Polydex), Boynton Beach, Florida, announced that on September 2, 1992, a patent application had been filed with the United States Patent Office on a new drug invention...

Small business innovation research grant awarded. (ImmuCell Corp.)
September 28, 1992... ImmuCell Corp. ImmuCell Corp., Portland, Maine, announced that it has been awarded a $50,000 grant from the U.S. National Institute of Allergy and Infectious Diseases for the study of immunotherapy of Crytosporidium infections. ...

French fail in bid to claim more funds from HIV test. (Washington, D.C.)
September 28, 1992... Washington, D.C. French members of the French and American AIDS Foundation formally asked September 16, 1992, for all of the royalties from HIV diagnostic test, but the motion died when U.S. members voted against it. When the four...

Director: AIDS activists challenging tradition. (Bernadine Healey) (U.S. National Institutes of Health)
September 28, 1992... U.S. NIH AIDS activists may be using unorthodox means to draw attention to their cause, but it's working, the director of the U.S. National Institutes of Health (NIH) said. "I think they have ushered in a whole new wave of...

HIV-infected athletes may have to circumvent rules for 1996 Olympics. (U.S. Department of Health and Human Services)
September 28, 1992... U.S. HHS The 1996 Olympics, to be held in Atlanta, Georgia, will not be an exception to the U.S. Health and Human Services (HHS) rule barring HIV-infected persons from visiting the U.S. Currently HIV-infected persons must receive...

Activists assail Mason on marijuana use. (James Mason, Public Health Service director) (Washington, D.C.)
September 28, 1992... Washington, D.C. Over 70 members of ACT UP/DC (AIDS Coalition to Unleash Power/Washington, D.C.) delivered a letter September 21, 1992, demanding expanded access to marijuana for people with AIDS to the director of the U.S. Public...

Study finds children confused about AIDS. (California)
September 28, 1992... California Elementary school children are very confused about what causes AIDS and how the disease is transmitted, according to a new study by a research team at the University of California, San Francisco (UCSF). "The older the...

Incidence of viral sexually transmitted diseases skyrockets in developed countries. (Decision Resources study)
September 28, 1992... Decision Resources Growth of antiviral therapies for sexually transmitted diseases (STDs) will largely outpace antibiotic therapies in most of Western Europe, Japan and the U.S. through the mid-1990s. In 1991, more than 80 percent...

AIDS creates new untouchable class. (India)
September 28, 1992... India AIDS is creating a new class of "untouchables" in India, a society bewildered by the spread of the disease despite its conservatism, family values and religious traditions. Ignorance, even among the medical community, is a...

Why AIDS is so difficult to fight. (India)
September 28, 1992... India The fight against AIDS in India is encountering obstacles of poverty, illiteracy and sexual modesty. A man is dying slowly of AIDS in a government hospital, but he doesn't know it. Doctors say he's uneducated and will never...

Hotel rejects American AIDS patient. (Japan)
September 28, 1992... Japan A Tokyo hotel refused to provide accommodations for an American AIDS patient who was in Japan to speak at a symposium on the disease, hotel officials said September 15, 1992. Organizers of the symposium, entitled "Living...

CD4 epitope masking by gp120/anti-gp120 antibody complexes in AIDS. (Research Report)
September 28, 1992... CD4 Epitope Masking by gp120/Anti-gp120 Antibody AUTHORS: R. Zamarchi, M. Veronese, G. DeSilvestro, A. Barelli, A. Borri, A. Amadori and L. Chieco-Bianchi. Institute of Oncology, University of Padova Central Laboratory Unit;...

CD5+ B cells during HIV infection. (Research Report)
September 28, 1992... AUTHORS: A. Amadori, M. Mion, S. Indraccolo, M. Panozzo, E. Francavilla and L. Chieco-Bianchi. Institute of Oncology, University of Padova; Biotechnology Section; Infectious Disease Unit; Padova, Italy. According to an abstract...

HIV-1 infection of both T and B lymphocytes in IVDU coinfected by HTLV-II. (intravenous drug users) (Research Report)
September 28, 1992... CD5+ B Cells during HIV Infection AUTHORS: C. Casoli, L. Mori, D. Zella, F. Lori, P. Lusso, G. Achilli, E. Cattaneo and U. Bertazzoni. University of Parma, Italy; IGBE-CNR, Pavia, Italy; LTBC, NCI, Bethesda, Maryland; IRCCS Pol.,...

Quantitation of HIV-1 RNA viremia and infectious virus-carrying cell frequency in the blood of HIV-1 infected symptom-free individuals. (Research Report)
September 28, 1992... AUTHORS: W. Lu, J. Shih and D. and J. Andrieu. Laboratory of Tumor Immunology, Laennec Hopital, Universite de Paris V, Paris, France; Department of Transfusion Medicine, National Institutes of Health, Bethesda, Maryland. According to...

Quantitation of HIV RNA in serum from HIV-infected subjects. (Research Report)
September 28, 1992... AUTHORS: S. Escaich, D. Lepot, P. Rougier, J. Lamelin and C. Trepo. INSERM; Hotel-Dieu; Lyon, France. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam, the Netherlands,...

HIV-1 infection of thymus in vivo: molecular evidence for a thymic viral variant. (Research Report)
September 28, 1992... AUTHORS: M. Calabro, C. Zanotto, A. DeRossi and L. Chieco-Bianchi. Institute of Oncology, University of Padova, Italy. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam,...

Silent (?) HIV-1 carriers among Ethiopian Jews: epidemiological and immunological implications. (Research Report)
September 28, 1992... AUTHORS: T. Jehuda-Cohen, A. Vonsover and Z. Bentwich. Clinical Immunology, Kaplan Hospital; Virology, Tel Hashomer Hospital; Israel. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held...

Inhibition of simian immunodeficiency virus (SIV) from African green monkeys by TIBO and HEPT derivatives. (reverse transcriptase inhibitors) (Research Report)
September 28, 1992... AUTHORS: Z. Debyser, K. DeVreese, N. Yamamoto, R. Pauwels, J. Anne, E. DeClercq and J. Desmyter. J. Rega Institute for Medical Research, Katholieke Universiteit Leuven, 10 Minderbroedersstraat, Leuven, Belgium. According to an...

Association of CD4+ cell depletion in HIV infected patients with gp120-immunoglobulin-complement complexes on the surface of CD4+ cells. (Research Report)
September 28, 1992... AUTHORS: V. Daniel, P. Caner, P. Andrej, R. Weimer, R. Zimmermann, A. Huth-Kuhne and G. Opelz. Institute of Immunology, University of Heidelberg; Rehabilitation Hospital and Hemophilia Center, Heidelberg, Germany. According to an...

Zidovudine alone versus zidovudine and acyclovir as treatment for patients with HIV disease. (Research Report)
September 28, 1992... AUTHORS: P. Salvato, C. Thompson, S. Stroud, B. Knight and E. Carroll. Houston Immunological Institute, Houston, Texas. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam,...

3'-azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation. (Periodical Report)
September 28, 1992... SOURCE: Proceedings of the National Academy of Sciences, September 1992;89(17):8361-8365. Zidovudine (AZT) has a syncytium-reducing effect in addition to its inhibitory effect on reverse transcriptase, a new study shows. Robert...

Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. (Periodical Report)
September 28, 1992... SOURCE: Proceedings of the National Academy of Sciences, September 1992;89(17):8356-8360. Binding of HIV to cells that do not express the CD4 receptor depends upon a membrane-associated C-type mannose-binding protein, a new study...

Examination of sera from human immunodeficiency virus type-1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity. (Periodical Report)
September 28, 1992... SOURCE: Journal of Virology, September 1992;66(9):5210-5215. Most HIV-1-infected people in both the U.S. and Africa have antibodies directed against the V3 region of the viral envelope - the so-called principal neutralizing domain of...

Epidemiology of AIDS in females with hemophilia and other chronic bleeding disorders in the United States - comparisons with males with chronic bleeding disorders and AIDS and with nonhemophiliac female blood-transfusion recipients with AIDS. (Periodical Report)
September 28, 1992... SOURCE: American Journal of Hematology, September 1992;41(1):19-23. Women with chronic bleeding disorders survive after an AIDS diagnosis as long as men with chronic bleeding disorders, a CDC study indicates. However, survival...

Multiple false-positive serologic tests for HIV, HTLV-I and hepatitis-C following influenza vaccination, 1991. (Periodical Report)
September 28, 1992... SOURCE: The Journal of the American Medical Association, August 26, 1992;268(8):1015-1017. Most blood donors who test false positive for HIV, HTLV-I and Hepatitis-C (HPC) received flu vaccines shortly before donation, a study...

Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. (Periodical Report)
September 28, 1992... SOURCE: Proceedings of the National Academy of Sciences, September 1992;89(17):8351-8355. A British AIDS research team suggests that cyclosporin A (CsA) be reevaluated as an AIDS therapeutic. Cambridge University researcher...

Herpes zoster ophthalmicus - an early pointer to HIV-1 positivity in young African patients. (Periodical Report)
September 28, 1992... SOURCE: Scandinavian Journal of Immunology, 1992;36(Suppl. 11):67-68. Herpes zoster ophthalmicus (HZO) is indicative of HIV infection in young African patients. South African physicians G.N. Palexas and N.H. Welsh report the...

Derivation of a biologically contained replication system for human immunodeficiency virus type-1. (Periodical Report)
September 28, 1992... SOURCE: Proceedings of the National Academy of Sciences, August 15, 1992;89(16):7678-7682. Duke University researchers report the development of a culture system using a safe, replication-incompetent form of HIV. The HIV-1 used...

U.S. response to AIDS is malpractice, AIDS expert says. (Donald P. Francis) (U.S. Centers for Disease Control)
September 21, 1992... U.S. CDC The U.S. national response to AIDS "approaches public health malpractice," claims Donald P. Francis, a founding member of the AIDS Task Force at the U.S. Centers for Disease Control (CDC). Francis' remarks, published in...

Advocacy group charges bias in National Guard dismissal. (HIV-infected aircraft technician suing for unlawful discrimination) (Puerto Rico)
September 21, 1992... Puerto Rico A coalition of lawyers in Puerto Rico is furious over the U.S. District Court's dismissal of a case involving an aircraft technician discharged from the Puerto Rico Air National Guard after he tested positive for HIV. The...

AIDS vaccine not likely, Sabin says. (Dr. Albert Sabin) (North Carolina)
September 21, 1992... North Carolina Dr. Albert Sabin, who developed the first oral vaccine for polio, says researchers simply do not know enough about the nature of HIV to be testing worthwhile vaccines. Sabin said that while vaccines have been...

TB drug dangerous for AIDS patients. (tuberculosis drug thiacetazone) (World Health Organization)
September 21, 1992... WHO Doctors at the World Health Organization (WHO) in Geneva, Switzerland, are warning that a drug widely used in Africa to combat tuberculosis (TB) should not be given to patients with HIV. The drug, thiacetazone, causes skin...

Workers infected with simian AIDS virus show no signs of disease. (U.S. Centers for Disease Control)
September 21, 1992... U.S. CDC Two laboratory workers who were infected with simian AIDS show no sign of developing the disease, U.S. health officials said. Repeated laboratory tests of the workers' blood indicated their bodies were able to fight off...

Ethicists criticize use of HIV patient for baboon transplant. (Pennsylvania)
September 21, 1992... Pennsylvania Medical ethicists criticized University of Pittsburgh (Pitt) Medical Center, Pittsburgh, Pennsylvania, doctors for using a man infected with HIV for the first transplant of a baboon liver into a human. "I'm concerned...

Blood bank seeks new trial in AIDS case. (United Blood Services) (Colorado)
September 21, 1992... Colorado A blood bank that was ordered to pay $6.6 million to a woman who received a transfusion contaminated with HIV is seeking a new trial on grounds that the woman died the day before the verdict was issued. Lawyers for United...

Blood bank, hospital defend themselves in key AIDS case. (New York Blood Center; New York Hospital)
September 21, 1992... New York Hospitals should not be held liable for the purity of blood collected and tested by outside agencies, even if it's transfused into patients by hospital personnel, a lawyer has argued before New York's highest court. ...

Condom vending machine joins fight against AIDS. (Zimbabwe)
September 21, 1992... Zimbabwe Vending machines are being used to dispense condoms in African nation of Zimbabwe. Old news in Western countries and some African countries, the condom vending machines are a novelty in Zimbabwe, where many have welcomed...

Sex-tourists add to AIDS problem. (Sri Lanka)
September 21, 1992... Sri Lanka Non-governmental organizations have begun to take steps to eradicate child prostitution on the island nation of Zimbabwe. At least 30,000 children between the ages of six to 15 are making a living offering their bodies...

Update on MAC in AIDS patients presented at conference. (Mycobacterium avium-intracellulare complex) (Pacific Medical Center)
September 21, 1992... Pacific Medical Center Organisms of the Mycobacterium avium-intracellulare complex (MAC) have now become the most common cause of systemic bacterial infection and a leading cause of death in patients with HIV disease. In fact, say...

Doctors fear 15,000 might have HIV. (Bangladesh)
September 21, 1992... Bangladesh Experts fear the number of HIV-infected patients in Bangladesh might be as high as 15,000, even though doctors have detected only nine cases so far, Dhaka's Daily Star reported September 7, 1992. "As there have been...

Leucomax granulocyte macrophage colony stimulating factor approval announced. (molgramostim) (Europe)
September 21, 1992... Europe Schering-Plough Corp., Madison, New Jersey, and Sandoz Pharma Ltd., Basel, Switzerland, announced that the European Community's Committee for Proprietary Medicinal Products (CPMP) has recommended approval of Leucomax...

$1.8 million NIH grant for new anti-HIV collaboration announced. (National Institutes of Health) (Agouron Pharmaceuticals)
September 21, 1992... Agouron Pharmaceuticals Agouron Pharmaceuticals Inc., San Diego, California, announced that it will cooperate with two private biotechnology firms - NeXagen Inc. of Boulder, Colorado, and Selectide Corp. of Tucson, Arizona - in a...

Longer term follow-up of psychiatric disorder in HIV. (Research Report)
September 21, 1992... AUTHORS: H. Atkinson, T. Patterson, J. Summers, S. Brown, W. Whitehall, A. Sciolla, I. Grant and the HNRC Group. University of California and VA Medical Center, San Diego, California. According to an abstract submitted by the authors...

Foscarnet and ganciclovir combination therapy for CMV-disease. (cytomegalovirus) (Research Report)
September 21, 1992... AUTHORS: B. Salzberger, M. Schrappe, L. Mantovani, A. Hiersche, A. Schwenk, G. Fatkenheuer and V. Diehl. Department of Internal Medicine I, University of Cologne, Germany. According to an abstract submitted by the authors to the VIII...

Aminosidine for the treatment of cryptosporidial diarrhoea in AIDS. (Research Report)
September 21, 1992... AUTHORS: J. Drake, L. Cattera, P. Olliaro, J. Sweeney, C. Blanshard, B. Gazzard and A. Pinching. Farmitalia Carlo Erba, Milan, Italy; St. Mary's Hospital, London; Westminster Hospital, London, United Kingdom. According to an abstract...

The relative safety of didanosine and zidovudine in the ACTG 116B/117 - a randomized, double-blind trial. (Research Report)
September 21, 1992... AUTHORS: L. Smaldone, M. Beltangady, S. Lagakos, D. Richman, R. Dolin, C. Pettinelli, A. Schindzielorz, A. Cross, J. Kahn and AIDS Clinical Trials Group 116B/117 Study Team, NIAID, and Bristol-Myers Squibb. According to an abstract...

Safety experience with dideoxycytidine (ddC) in an expanded access population. (Research Report)
September 21, 1992... AUTHORS: J. Lieberman, C. Nauss-Karol, M. Salgo, I. Kaul, J. Yucaitis and W. Soo. Hoffmann-La Roche Inc., Nutley, New Jersey; ddC Coordinating Center, Wellesley, Massachusetts. According to an abstract submitted by the authors to the...

Bioluminescence assay for detection of replicating HIV. (Research Report)
September 21, 1992... AUTHORS: Z. Bentwich, P. Lawatti, A. Vonsover, S. Ulitzur, S. Honigman and S. Israel. Clinical Immunology, Kaplan Hospital, Rehovot, Israel; Virology, Tel Hashomer; Virolume Ltd. Molecular Genetics, Hebrew University Medical School,...

Cofactors in murine AIDS: the effect of autoimmunity. (Research Report)
September 21, 1992... AUTHORS: Z. Weisman, E. Mozes, N. Harpaz, S. Eitan, A. Meshorer and Z. Bentwich. R. Ben-Ari Institute of Clinical Immunology, Kaplan Hospital; Weizmann Institute of Science, Rehovot, Israel. According to an abstract submitted by the...

"A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection," and "Nucleoside therapy for HIV infection - some answers, many questions." (summaries of 2 articles from The New England Journal of Medicine) (Periodical Report)
September 21, 1992... SOURCE: The New England Journal of Medicine, August 27, 1992;327(9):581-587, 639-641. Didanosine (2',3'-dideoxyinosine or ddI) slows progression of HIV disease - but does not prolong survival - in some patients who have received...

No evidence for female-to-female HIV transmission among 960,000 female blood donors. (Periodical Report)
September 21, 1992... SOURCE: Journal of Acquired Immune Deficiency Syndromes, September 1992;5(9):853-855. No female-to-female transmission of HIV occurred among 960,000 female blood donors assessed in 1990, a large-scale study indicates. Lyle R....

Further studies of salivary inhibition of HIV-1 infectivity. (Periodical Report)
September 21, 1992... SOURCE: Journal of Acquired Immune Deficiency Syndromes, September 1992;5(9):898-903. There appear to be several mechanisms by which saliva inhibits HIV-1 infectivity, an U.S. National Institutes of Health (NIH) study shows. ...

Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men. (Periodical Report)
September 21, 1992... SOURCE: Archives of Internal Medicine, August 1992;152(8):1673-1676. Homosexual men with HIV infection are significantly more likely to have evidence of anal human papilloma virus (HPV) infection than seronegative homosexual men, a...

Current trends: publicly funded HIV counseling and testing - United States, 1991. (Periodical Report)
September 21, 1992... SOURCE: Morbidity and Mortality Weekly Report, August 28, 1992. "Human immunodeficiency virus (HIV) counseling and testing (CT) services provided by health departments are a major component of the national HIV-prevention program. The...

Hearing on expansion of AIDS surveillance case definition. (U.S. Centers for Disease Control)
September 14, 1992... U.S. CDC AIDS experts and activists convened September 2, 1992, to discuss the expansion of the AIDS case definition proposed by the U.S. Centers for Disease Control (CDC). Patient and physician advocates voiced concerns that the...

Proposed AIDS definition unreliable, public health study says. (CD4+ counts can vary) (Johns Hopkins School of Public Health)
September 14, 1992... Johns Hopkins School of Public Health Citing findings from a large multi-center study, lead authors from the Johns Hopkins School of Public Health say that the basis of the Centers for Disease Control's (CDC) proposal to redefine the...

HIV treatment may cost $15 billion by 1995. (Agency for Health Care Policy and Research)
September 14, 1992... Agency for Health Care Policy and Research The cost of treating all persons in the United States who are HIV(+) - including those diagnosed with AIDS -will reach $15.2 billion by 1995, according to new estimates by Fred J. Hellinger,...

Blood donors more likely to reveal HIV risks to computer. (computer-based screening) (American Medical Association)
September 14, 1992... American Medical Association Potential blood donors may be more comfortable revealing possible risk of HIV transmission to a computer than to a human, according to a study published in the September 9, 1992 issue of the Journal of the...

Three Haitians with HIV allowed to get medical treatment in U.S. (Washington, D.C.)
September 14, 1992... Washington, D.C. The U.S. government has waived its rules and allowed three Haitians with HIV to enter the United States for medical treatment, but a spokesman said September 3, 1992, that the action is not a change in administration...

Company supports hurricane relief effort. (Hurricane Andrew) (Burroughs Wellcome)
September 14, 1992... Burroughs Wellcome To support the restoration of critical services and supplies, Burroughs Wellcome Co., Research Triangle Park, North Carolina, is working through several state and local government and voluntary agencies in hurricane...

State needle exchange bills pass. (California)
September 14, 1992... California With bipartisan support in the California State Assembly and State Senate, two identical needle exchange bills have been passed and sent to Governor Pete Wilson for his signature. The landmark bills were authored by the...

Patent approval on AR-121 for HIV and systemic fungal infections received. (intravenous formulation of nystatin) (Argus Pharmaceuticals)
September 14, 1992... Argus Pharmaceuticals The U.S. Patent and Trademark Office has issued Houston, Texas-based Argus Pharmaceuticals Inc. an official "Notice of Allowance" for its patent application relating to the manufacturing process of AR-121 ...

Bacterium that causes Whipple's disease identified; may cause some AIDS wasting and diarrhea. (Stanford University)
September 14, 1992... Stanford University Scientists have identified the bacterium responsible for Whipple's disease, an infectious disease first described in 1907. Since then, hundreds of researchers have tried unsuccessfully to isolate the organism...

Common spermicide doesn't protect high-risk women from HIV infection. (contraceptive sponge with nonoxynol 9) (University of Washington)
September 14, 1992... University of Washington A contraceptive sponge with the common spermicide nonoxynol 9 is not effective for women at high risk for HIV infection and other sexually transmitted diseases, according to a study published in the July 22,...

U.S. physicians display negative attitude concerning AIDS care. (American Medical Association)
September 14, 1992... American Medical Association A study of resident physicians in 10 American states, three regions in France and all 19 Canadian provinces, shows that future primary care providers in the U.S. have the most negative attitudes about...

Researchers report technique keeps HIV dormant. (altering white blood cells with antibodies to CD14) (Thomas Jefferson University)
September 14, 1992... Thomas Jefferson University A laboratory technique that keeps HIV dormant inside some blood cells might lead to a way to prevent the disease from overwhelming a person's immune system, researchers reported. In the July 15, 1992,...

Atlanta legislation would require sale of condoms with liquor. (Georgia)
September 14, 1992... Georgia In Atlanta, Georgia, liquor stores, restaurants, caterers and even the city's orchestra would be required to sell condoms under a proposed ordinance aimed at stemming the spread of AIDS. The City Council's Public Safety...

Safety and immunogenicity of IIIB rgp120/HIV-1 vaccine in seronegative volunteers. (Research Report)
September 14, 1992... AUTHORS: M. Clements, R. Belshe, A. Duliege, D. Schwartz, G. Gorse, A. Izu, A. Ammann and the NIAID-sponsored AIDS Vaccine Clinical Trials Network. Johns Hopkins University, Baltimore, Maryland; St. Louis University, St. Louis, Missouri;...

Combination prime-boost approach to HIV vaccination in seronegative individuals: enhanced immunity with additional subunit gp160 protein boosting. (Research Report)
September 14, 1992... AUTHORS: J. McElrath, E. Peterson, J. Dragavon, D. Berger, M. Hoffman, S. Klucking, P. Greenberg and L. Corey. University of Washington School of Medicine, Seattle, Washington. According to an abstract submitted by the authors to the...

Sexually transmitted diseases and HIV among young Thai men. (Research Report)
September 14, 1992... AUTHORS: S. Elumtrakul, A. Matanasarawoot, S. Tulvatana, D. Celentano, K. Nelson and N. Wright. Chaing Mai University; Royal Thai Army and Air Force; Johns Hopkins University, Baltimore, Maryland; RWJ Medical School, New Jersey. ...

Gender differences in the natural history of HIV infection. (Research Report)
September 14, 1992... AUTHORS: S. Stabo, L. Miller, H. Sacke, A. Gurtman, D. Rose, R. Kee, T. Cheung and S. Cohen. Mount Sinai School of Medicine, New York, New York. According to an abstract submitted by the authors to the VIII International Conference on...

Gender differences in the spectrum of HIV disease. (Research Report)
September 14, 1992... AUTHORS: T. Creagh, M. Thompson, A. Morris, ARCA Spectrum of Disease Working Group and B. Whyte. AIDS Research Consortium of Atlanta Inc.; Emory University School of Medicine; Department of Human Resources; Atlanta, Georgia. ...

What proportion of HIV infections are attributable to genital ulcers in Sub-Saharan Africa? (Research Report)
September 14, 1992... AUTHORS: R. Hayes and K. Schulz. London School of Hygiene and Tropical Medicine, London, United Kingdom. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam, the...

Age accelerates the progression from HIV-seroconversion to AIDS in women. (Research Report)
September 14, 1992... AUTHORS: Italian Seroconversion Study, AIDS Unit, Istituto Superiore di Sanita, Rome, Italy. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam, the Netherlands, July...

Women with HIV disease: clinical progression and survival in a cohort followed at a university medical center. (Research Report)
September 14, 1992... AUTHORS: C. Benson, B. Sha, P. Urbanski, J. Pottage and H. Kessler. Rush Medical College, Chicago, Illinois. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam, the...

Natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988-1991. (Research Report)
September 14, 1992... AUTHORS: P. Msellati, V. Leroy, P. Lepage, D. Hitimana, B. Muakamabano, C. Van Geothem, P. Van de Perre and F. Dabis. INSERM U 330, Bordeaux, France; Department of Pediatrics, Centre Hospitalier de Kigali, Rwanda; AIDS Reference...

CD4 status and p24 antigenemia - are they useful predictors of survival in HIV-infected children receiving antiretroviral therapy? (Periodical Report)
September 14, 1992... SOURCE: American Journal of Diseases of Children, August 1992;146(8):932-936. Low age-adjusted CD4 T-cell counts in children with HIV infection are associated with poor prognosis, but do not rule out prolonged survival. Karina M....

Pneumococcal disease during HIV infection - epidemiologic, clinical and immunologic perspectives. (Periodical Report)
September 14, 1992... SOURCE: Annals of Internal Medicine, August 15, 1992;117(4):314-324. Prevention of Streptococcus pneumoniae infection -the leading cause of bacterial respiratory disease in adults and children with HIV infection - may depend upon the...

HIV infection among patients in United States acute care hospitals - strategies for the counseling and testing of hospital patients. (Periodical Report)
September 14, 1992... SOURCE: New England Journal of Medicine, August 13, 1992;327(7):445-452. CDC researchers suggest that routine, voluntary testing of hospital patients could potentially double the number of patients with recognized HIV infection. ...